Navigation Links
Mystery unfolds about the Ginkgo biloba extract!

Georgetown University Medical Centre scientists have unravelled mystery surrounding the leaf extract of Ginkgo biloba tree in reducing aggressive cancer in // animals.

Anticancer Research journal (Jan-Feb) features the study. The investigators reported that treating mice with this extract before and after implanting human breast or brain (glioma) tumours decreased expression of a cell receptor associated with invasive cancer.

An 80 percent decreased incidence was observed as long as the extract was used, compared to untreated mice, and also reduced the size of the brain tumours, but temporarily, and to a lesser extent.

Ginkgo biloba extract is a popular supplement that comes from the leaves of the Gingko tree, which is indigenous to Japan, Korea and China but can be found all over the world.

In the words of senior author, Vassilios Papadopoulos, DPharm, PhD, Director, Biomedical Graduate Research Organization and Associate Vice President of Georgetown University Medical Centre, "It is very encouraging that Ginkgo biloba appeared to reduce the aggressiveness of these cancers, because it suggests that the leaves could be useful in some early stage diseases to prevent them from becoming invasive, or spreading. But I must stress that this is a study in mice, and so we cannot say what anticancer effects, if any, Gingko biloba might offer humans. In fact, we have found that most life forms, including plants, insects, and animals, have receptors like these that help regulate growth. Accelerated growth requires production of new cell membranes, and one of the main components of membranes is cholesterol."

The researchers also knew that steroids help regulate brain function, and they found over-expression of PBR is also associated with a variety of neurological disorders.

On stressing the need for this new study he said that one aim of this new study, then, was to find whether other cancer cell lines also over- express PBR. The other part of the research was to see if Ginkgo biloba would show any anticancer effects on these cancer cell lines, and concluded that the extract did nothing to cancers that were not invasive, but significantly slowed the growth of aggressive cancer cells.

The next step of Papadopoulos is to examine the notion that a cancer diagnosis might increase production of stress steroids such as corticosteroids through PBR over-expression, and it is this stress that, in effect, pushes a tumour to become invasive. He says, “Ginkgo biloba could possibly reduce this stress by tamping down PBR."


'"/>




Related medicine news :

1. Mystery behind Preeclampsia uncovered
2. Understanding The Mystery Behind Sleepless Nights
3. Mystery of nacrolepsy uncovered
4. Cholesterol Mystery Solved By Nobel Laureates
5. A Step Towards Unraveling The Schizophrenia And Depression Mystery
6. Mystery Surrounding Use Of Abortion Pill Yet To Be Resolved
7. $2.4 Million Grant To Unravel The Mystery Of Language Recognition.
8. Mystery behind Brain activity during recalling events disentangled
9. Mystery over bird flu infection to Ms. Zhou – China’s 7th bird flu victm
10. Mystery Of The Placebo Effect, Yet To Be Solved
11. Dry Earwax Mystery Solved: Ear Wax Gene Identified
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2017)... ... 29, 2017 , ... AngioGenesis Labs sold 300 bottles of ... Labs, makers of HeartBoost, BrainBest and BeautyBest, achieved these results while doing a ... over the counter heart healthy drink, can reduce Arterial Plaque, Lower Blood Pressure, ...
(Date:3/29/2017)... ... ... Dr. Angela Cotey, a noted general dentist in Mt. Horeb, is now ... without a referral. Dr. Cotey knows that interceptive orthodontics in Mt. Horeb, ... receive early treatment, they may achieve straight teeth with less treatment in their teenage ...
(Date:3/29/2017)... Baltimore, MD (PRWEB) , ... March 29, 2017 , ... ... Maryland, is proud to announce the finalization of the company’s executive management team with ... team and leading operations is Curio Wellness’ Chief Operating Officer, Ted Dumbauld , ...
(Date:3/29/2017)... ... 29, 2017 , ... Immunotherapy has emerged as one of the most promising ... to be the next revolution in our fight against this complex disease. One of ... immune checkpoint inhibitors such as PD-1 and PD-L1 inhibitors. , While a few single ...
(Date:3/29/2017)... ... March 29, 2017 , ... The Wharton School of the ... Taffet Moelis, W’81, have made a $10 million gift to establish the Ken ... will provide a pathway to a Wharton MBA for highly-qualified Penn undergraduates whose academic ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , March 29, 2017   Dynatronics ... today the appointment of Cynthia L. McHenry ... will be responsible for leading Dynatronics manufacturing, distribution, ... will report to Dynatronics, CEO Kelvyn H. ... concludes an extensive search process conducted by the ...
(Date:3/29/2017)... , March 29, 2017 Neurim ... which Exeltis will obtain exclusive marketing rights for Neurim,s new Rx ... ... drug targeted to treat sleep disorders in children with Autism Spectrum ... first sleep medication approved for children. The collaboration with ...
(Date:3/29/2017)... SHELTON, Connecticut , March 29, 2017 /PRNewswire/ ... cybersecurity company Sectra (STO: SECT B) ... (UPHS) will install Sectra PACS in their healthcare ... and the Epic EMR, will enable access and ... clinical pathway. Additionally, UPHS and Sectra will enter ...
Breaking Medicine Technology: